A comparative study on the pulmonary delivery of tobramycin encapsulated into liposomes and PLA microspheres following intravenous and endotracheal delivery
Authors:
- H.O. AlparHAH.O. Alpar
- A.J. AlmeidaAAA.J. Almeida
- 1 July 1995
- journal article
- Published by Elsevier in Journal of Controlled Release
- Vol. 35 (1) , 41-48
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Liposomes for controlled delivery of drugs to the lung.Thorax, 1992
- Factors Affecting the Release Rate of Terbutaline from Liposome Formulations After Intratracheal Instillation in the Guinea PigPharmaceutical Research, 1992
- Inhibition of Pseudomonas aeruginosa exoenzyme expression by subinhibitory antibiotic concentrationsAntimicrobial Agents and Chemotherapy, 1989
- Activity against rhinoviruses, toxicity, and delivery in aerosol of enviroxime in liposomesAntimicrobial Agents and Chemotherapy, 1988
- NOVEL MODES OF ACTION OF AMINOGLYCOSIDE ANTIBIOTICS AGAINST PSEUDOMONAS AERUGINOSAThe Lancet, 1988
- Rational parameters for antibiotic therapy in patients with cystic fibrosisInfection, 1987
- Liposomes as carriers of antimicrobial agentsAntimicrobial Agents and Chemotherapy, 1987
- Liposome Disposition In Vivo VI: Delivery to the LungJournal of Pharmaceutical Sciences, 1984
- Aerosolized Ribavirin Treatment of Infants with Respiratory Syncytial Viral InfectionNew England Journal of Medicine, 1983
- The pathogenesis and treatment of pulmonary infections in patients with cystic fibrosisThe Journal of Pediatrics, 1981